ADPT
Adaptive Biotechnologies Corporation
NASDAQ · Healthcare · Biotechnology · US
$24.28
−1.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1507.50x
- P/S forward
- 12.20x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 27.11x
- Price / sales
- 12.58x
- Price / cash flow
- -184.44x
Enterprise value
- Enterprise value
- $3.9B
- EV / sales
- 12.82x
- EV / EBITDA
- -247.40x
- EV / EBIT
- -105.42x
- Market cap
- $3.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026